Company profile AVDL
After 39 days of this quarter the interest is at 115.0. Based on that we can calculate that during remaining 52 days it will total up to 268.0. Avadel Pharmaceuticals expected interest is significantly higher compared to previous quarter (+339.3%) and same quarter last year (+48.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 105 12.9% QoQ | 75 -28.6% QoQ | 105 40.0% QoQ |
| 2020 | 83 -10.8% YoY -21.0% QoQ | 180 71.4% YoY 116.9% QoQ | 134 78.7% YoY -25.6% QoQ | 127 21.0% YoY -5.2% QoQ |
| 2021 | 108 30.1% YoY -15.0% QoQ | 55 -69.4% YoY -49.1% QoQ | 155 15.7% YoY 181.8% QoQ | 176 38.6% YoY 13.5% QoQ |
| 2022 | 195 80.6% YoY 10.8% QoQ | 109 98.2% YoY -44.1% QoQ | 139 -10.3% YoY 27.5% QoQ | 109 -38.1% YoY -21.6% QoQ |
| 2023 | 180 -7.7% YoY 65.1% QoQ | 105 -3.7% YoY -41.7% QoQ | 123 -11.5% YoY 17.1% QoQ | 61 -44.0% YoY -50.4% QoQ |
| 2024 | 115 -36.1% YoY 88.5% QoQ | - | - | - |
The average 5 years interest of Avadel Pharmaceuticals was 9.7 per week. The last year interest of Avadel Pharmaceuticals compared to the last 5 years has changed by -3.3%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 15.38%.
There is not enough data for LUMRYZ narcolepsy treatment to provide analysis
There is not enough data for LUMRYZ narcolepsy treatment to provide correlation calculation
There is not enough data for LUMRYZ narcolepsy treatment to provide analysis
After 39 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 52 days it will total up to 93.0. Avadel Pharmaceuticals news expected interest is significantly higher compared to previous quarter (+72.2%) and same quarter last year (+52.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 41 inf% QoQ | 110 168.3% QoQ | 82 -25.5% QoQ |
| 2020 | 44 inf% YoY -46.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 44 -60.0% YoY inf% QoQ | 66 -19.5% YoY 50.0% QoQ |
| 2021 | 65 47.7% YoY -1.5% QoQ | 126 inf% YoY 93.8% QoQ | 147 234.1% YoY 16.7% QoQ | 60 -9.1% YoY -59.2% QoQ |
| 2022 | 17 -73.8% YoY -71.7% QoQ | 109 -13.5% YoY 541.2% QoQ | 99 -32.7% YoY -9.2% QoQ | 76 26.7% YoY -23.2% QoQ |
| 2023 | 61 258.8% YoY -19.7% QoQ | 82 -24.8% YoY 34.4% QoQ | 115 16.2% YoY 40.2% QoQ | 54 -28.9% YoY -53.0% QoQ |
| 2024 | 40 -34.4% YoY -25.9% QoQ | - | - | - |
The average 5 years interest of Avadel Pharmaceuticals news was 5.51 per week. The last year interest of Avadel Pharmaceuticals news compared to the last 5 years has changed by 9.98%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 13.7%.
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Avadel Pharmaceuticals stock expected interest is significantly higher compared to previous quarter (+565.7%) and same quarter last year (+2018.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 31 | 70 125.8% QoQ | 29 -58.6% QoQ | 27 -6.9% QoQ |
| 2020 | 36 16.1% YoY 33.3% QoQ | 45 -35.7% YoY 25.0% QoQ | 39 34.5% YoY -13.3% QoQ | 37 37.0% YoY -5.1% QoQ |
| 2021 | 21 -41.7% YoY -43.2% QoQ | 41 -8.9% YoY 95.2% QoQ | 28 -28.2% YoY -31.7% QoQ | 25 -32.4% YoY -10.7% QoQ |
| 2022 | 76 261.9% YoY 204.0% QoQ | 18 -56.1% YoY -76.3% QoQ | 20 -28.6% YoY 11.1% QoQ | 63 152.0% YoY 215.0% QoQ |
| 2023 | 11 -85.5% YoY -82.5% QoQ | 22 22.2% YoY 100.0% QoQ | 7 -65.0% YoY -68.2% QoQ | 35 -44.4% YoY 400.0% QoQ |
| 2024 | 100 809.1% YoY 185.7% QoQ | - | - | - |
The average 5 years interest of Avadel Pharmaceuticals stock was 2.99 per week. The last year interest of Avadel Pharmaceuticals stock compared to the last 5 years has changed by 9.36%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 0.0%.
After 39 days of this quarter the interest is at 121.0. Based on that we can calculate that during remaining 52 days it will total up to 282.0. Excessive daytime sleepiness treatment expected interest is significantly higher compared to previous quarter (+129.3%) and same quarter last year (+100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 46 | 76 65.2% QoQ | 180 136.8% QoQ | 203 12.8% QoQ |
| 2020 | 82 78.3% YoY -59.6% QoQ | 245 222.4% YoY 198.8% QoQ | 197 9.4% YoY -19.6% QoQ | 147 -27.6% YoY -25.4% QoQ |
| 2021 | 341 315.9% YoY 132.0% QoQ | 62 -74.7% YoY -81.8% QoQ | 184 -6.6% YoY 196.8% QoQ | 307 108.8% YoY 66.8% QoQ |
| 2022 | 143 -58.1% YoY -53.4% QoQ | 288 364.5% YoY 101.4% QoQ | 89 -51.6% YoY -69.1% QoQ | 124 -59.6% YoY 39.3% QoQ |
| 2023 | 141 -1.4% YoY 13.7% QoQ | 138 -52.1% YoY -2.1% QoQ | 114 28.1% YoY -17.4% QoQ | 123 -0.8% YoY 7.9% QoQ |
| 2024 | 121 -14.2% YoY -1.6% QoQ | - | - | - |
The average 5 years interest of Excessive daytime sleepiness treatment was 12.84 per week. The last year interest of Excessive daytime sleepiness treatment compared to the last 5 years has changed by -13.4%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 10.32%.
After 39 days of this quarter the interest is at 106.0. Based on that we can calculate that during remaining 52 days it will total up to 247.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 179 | 305 70.4% QoQ | 374 22.6% QoQ | 210 -43.9% QoQ |
| 2020 | 272 52.0% YoY 29.5% QoQ | 309 1.3% YoY 13.6% QoQ | 173 -53.7% YoY -44.0% QoQ | 248 18.1% YoY 43.4% QoQ |
| 2021 | 150 -44.9% YoY -39.5% QoQ | 225 -27.2% YoY 50.0% QoQ | 425 145.7% YoY 88.9% QoQ | 208 -16.1% YoY -51.1% QoQ |
| 2022 | 302 101.3% YoY 45.2% QoQ | 78 -65.3% YoY -74.2% QoQ | 258 -39.3% YoY 230.8% QoQ | 215 3.4% YoY -16.7% QoQ |
| 2023 | 271 -10.3% YoY 26.0% QoQ | 317 306.4% YoY 17.0% QoQ | 174 -32.6% YoY -45.1% QoQ | 246 14.4% YoY 41.4% QoQ |
| 2024 | 106 -60.9% YoY -56.9% QoQ | - | - | - |
The average 5 years interest of Cataplexy treatment was 19.33 per week. The last year interest of Cataplexy treatment compared to the last 5 years has changed by -1.09%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -15.25%.
There is not enough data for Avadel Pharmaceuticals clinical trial to provide analysis
There is not enough data for Avadel Pharmaceuticals clinical trial to provide correlation calculation
There is not enough data for Avadel Pharmaceuticals clinical trial to provide analysis
There is not enough data for Avadel Pharmaceuticals Dublin headquarters to provide analysis
There is not enough data for Avadel Pharmaceuticals Dublin headquarters to provide correlation calculation
There is not enough data for Avadel Pharmaceuticals Dublin headquarters to provide analysis
After 34 days of this quarter the interest is at 277.0. Based on that we can calculate that during remaining 58 days it will total up to 750.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 371 |
| 2019 | 613 65.2% QoQ | 593 -3.3% QoQ | 481 -18.9% QoQ | 574 54.7% YoY 19.3% QoQ |
| 2020 | 508 -17.1% YoY -11.5% QoQ | 374 -36.9% YoY -26.4% QoQ | 504 4.8% YoY 34.8% QoQ | 357 -37.8% YoY -29.2% QoQ |
| 2021 | 429 -15.6% YoY 20.2% QoQ | 267 -28.6% YoY -37.8% QoQ | 600 19.0% YoY 124.7% QoQ | 474 32.8% YoY -21.0% QoQ |
| 2022 | 610 42.2% YoY 28.7% QoQ | 528 97.8% YoY -13.4% QoQ | 386 -35.7% YoY -26.9% QoQ | 597 25.9% YoY 54.7% QoQ |
| 2023 | 604 -1.0% YoY 1.2% QoQ | 754 42.8% YoY 24.8% QoQ | 639 65.5% YoY -15.3% QoQ | 277 -53.6% YoY -56.7% QoQ |
The average 5 years interest of Sodium oxybate was 40.38 per week. The last year interest of Sodium oxybate compared to the last 5 years has changed by 24.81%. The interest for Sodium oxybate is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 17.78%.
After 39 days of this quarter the interest is at 103.0. Based on that we can calculate that during remaining 52 days it will total up to 240.0. Avadel Pharmaceuticals -stock -company expected interest is significantly higher compared to previous quarter (+1233.3%) and same quarter last year (+471.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 27 | 8 -70.4% QoQ | 6 -25.0% QoQ | 37 516.7% QoQ |
| 2020 | 35 29.6% YoY -5.4% QoQ | 18 125.0% YoY -48.6% QoQ | 27 350.0% YoY 50.0% QoQ | 15 -59.5% YoY -44.4% QoQ |
| 2021 | 20 -42.9% YoY 33.3% QoQ | 19 5.6% YoY -5.0% QoQ | 21 -22.2% YoY 10.5% QoQ | 51 240.0% YoY 142.9% QoQ |
| 2022 | 37 85.0% YoY -27.5% QoQ | 27 42.1% YoY -27.0% QoQ | 19 -9.5% YoY -29.6% QoQ | 25 -51.0% YoY 31.6% QoQ |
| 2023 | 42 13.5% YoY 68.0% QoQ | 33 22.2% YoY -21.4% QoQ | 33 73.7% YoY 0.0% QoQ | 18 -28.0% YoY -45.5% QoQ |
| 2024 | 103 145.2% YoY 472.2% QoQ | - | - | - |
The average 5 years interest of Avadel Pharmaceuticals -stock -company was 2.38 per week. The last year interest of Avadel Pharmaceuticals -stock -company compared to the last 5 years has changed by 71.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 144.31%.